Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Study to Evaluate the Efficacy of Huaiqihuang Granule in Children With Primary Nephrotic Syndrome

NCT03332420 is registered in ClinicalTrials.gov with Qidong Gaitianli Medicines Co., Ltd as lead sponsor.

NCT NCT03332420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03332420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Study to Evaluate the Efficacy of Huaiqihuang Granule in Children With Primary Nephrotic Syndrome
Lead sponsor
Qidong Gaitianli Medicines Co., Ltd
Phase
Observational
Overall status
Completed
Start date
November 16, 2017
Completion date
August 31, 2021
Enrollment
1,507 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

nephrotic syndrome